28th Annual Lynn Sage Breast Cancer Symposium

Thursday, October 1, 2026, 7:30 AM - Sunday, October 4, 2026, 5:15 PM, Radisson Blu Aqua Hotel, Chicago, IL


This educational initiative was created to provide a dynamic forum for presenting, debating, and evaluating cutting-edge technology and innovative strategies in breast cancer treatment. It brings together leading national and international experts in medicine, surgery, pathology, and radiation oncology, fostering collaboration among global leaders to advance the management of breast cancer.

1. Apply evidence-based strategies to reduce breast cancer risk and manage survivorship complications, including lifestyle modification, menopausal symptoms, lymphedema, dermatologic toxicity, and genetic testing.
2. Interpret key breast pathology findings to support accurate diagnosis, risk stratification, and treatment planning.
3. Incorporate contemporary imaging technologies, including artificial intelligence, into breast cancer detection and surveillance.
4. Apply risk assessment tools and risk-based screening strategies to individualize breast cancer management.
5. Select evidence-based adjuvant systemic therapies across breast cancer subtypes, including endocrine therapy, HER2-directed therapy, and treatment of TNBC.
6. Evaluate local therapy and de-escalation strategies in breast cancer care, including radiotherapy decisions and management of patients with significant co-morbidities.
7. Develop multidisciplinary treatment strategies for advanced and recurrent breast cancer, including locoregional recurrence and metastatic disease.
8. Analyze emerging evidence and ongoing controversies to inform clinical decision-making, including DCIS, brain metastases, molecular progression, and antibody–drug conjugates.
9. Determine optimal axillary management strategies based on contemporary surgical and radiotherapeutic evidence.

Registration details COMING SOON!

The Northwestern University Feinberg School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

The Northwestern University Feinberg School of Medicine designates this live activity for a maximum of 22.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AMA PRA Category 1 Credits™ (22.75 hours), ABIM MOC Part 2 (22.75 hours), Non-Physician Attendance (22.75 hours)

Mitigation of Relevant Financial Relationships

Feinberg School of Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to control the content of a Continuing Education activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.